openPR Logo
Press release

Acute Myeloid Leukemia (AML) Therapeutics Market to Develop Rapidly by 2025

08-04-2017 12:25 PM CET | Health & Medicine

Press release from: Persistence Market Research

Acute Myeloid Leukemia (AML) Therapeutics Market to Develop

Leukemia are a heterogeneous group of cancers affecting the bone marrow and White Blood Cells (WBC). Leukemia is characterized by the rapid increase of abnormal blood cells growth or blasts, resulting in a decrease in the numbers of healthy, normal fully modified blood cells, leading to the typical symptoms of bleeding, anemia, and high risk of infection. Leukemia can grow along either the myeloid or lymphoid stem cell lines, it depends on the effect of genetic and epigenetic mutations on the progression of pluripotent stem cells to the various lines of mature cells which then pass into the blood. The effected line, combined with the rate of action and growth of disease reflects the four types of leukemias- Acute Myeloid Leukemia (AML), chronic lymphoblastic leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia. AML: Acute Myeloid Leukemia, is a serious condition, it’s the most common leukemia suffered by adult people. According to a report from American Cancer Society, the average age for first diagnostic for AML is 64. With few days without treatment, AML develops fast, in duration of few weeks, the patient becomes severely ill. Due to its fast onset and acuteness in nature, there is no staging system for Acute Myeloid Leukemia (AML).The treatment for Acute Myeloid Leukemia (AML) has changed in last 4 decades.

To access full report @

The drug approval process is difficult in AML, (many drugs have not been approved by USFDA, for instance Laromustine, Dacogen and Tipitarnib) efforts have been made to introduce new therapies in the AML market.

Primary drivers boosting the growth of acute myeloid leukemia (AML) therapeutics market are minimal but increased prevalence of acute myeloid leukemia (AML), increased drug approval rate for AML, classification of acute myeloid leukemia (AML) as an orphan disease. Over the forecast period, population of people over 65 year is anticipated to increase, which is another key driver for acute myeloid leukemia (AML) therapeutics market.

However, lack of targeted therapies in current acute myeloid leukemia (AML) therapeutics landscape, the drug difficult approval process in AML can hinder the growth of acute myeloid leukemia (AML) therapeutics market, but this restraint has opened an opportunity for key players to innovate acute myeloid leukemia (AML) therapeutics market.

The global acute myeloid leukemia (AML) therapeutics market is anticipated to show lucrative growth owing to increased investment in innovative technologies by key players. Players in this market using various strategies to fuel their global footprint and to gain a competitive edge. Product pipelines, new product launches, agreements and collaborations, acquisitions, mergers and clinical trials are some key strategies applied from global players in recent years are anticipated to give a robust hike to the market in the forecast period.

Geographically, acute myeloid leukemia (AML) therapeutics market is segmented into regions viz. North America, Latin America, Europe, Asia Pacific and Japan, Middle East and Africa. North America is anticipated to be major contributor to this market accounting maximum percent of share in AML therapeutics market followed by Europe. Slow but constant growth in prevalence for AML in North America is anticipated to fuel the growth in acute myeloid leukemia (AML) therapeutics market. In Asia pacific region, China and India are anticipated to show high growth in acute myeloid leukemia (AML) therapeutics market due to new developments in healthcare infrastructure in the region.

A sample of this report is available upon request @

The players in acute myeloid leukemia (AML) therapeutics market include Ambit Biosciences Corporation, Celgene Corporation, Cephalon Inc., Clavis Pharma ASA, Eisai Co. Ltd, Genzyme Corporation, and Sunesis Pharmaceuticals Inc., Abbvie Inc., Astellas Pharma Inc, CTI Biopharma Corp etc.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Myeloid Leukemia (AML) Therapeutics Market to Develop Rapidly by 2025 here

News-ID: 656515 • Views: 287

More Releases from Persistence Market Research

Intelligent Power Switches Market 2022 Trends, Share, Size, Growth, Opportunity …
Intelligent Power Switches Market 2022 Intelligent power switches are also called as smart power switches because of its advanced functionality. Intelligent power switches are used for high side and low side configurations and are designed for handling normal overload conditions in addition to several extraordinary conditions. Intelligent power switches finds their application in automotive, industrial and commercial sectors. Get Sample Copy of this Report@ In Intelligent power switches, control section and power stage is integrated on
Point-to-Multipoint Microwave Backhaul Market is expected to touch a US$ 927.3 M …
Point-to-Multipoint Microwave Backhaul Market 2022 The global point-to-multipoint microwave backhaul market is anticipated to reflect a revenue growth of US$ 927.3 Mn in 2025 from US$ 517.8 Mn in 2017, and is expected to witness a significant growth rate by registering a CAGR of 7.6% throughout the period of forecast, 2017 to 2025. An exhaustive market evaluation put forth by Persistence Market Research on the point-to-multipoint microwave backhaul market in a new research publication
Software Defined Security Market Trends, Drivers and Growth Projection Up to 203 …
Software Defined Security Market 2022 The global software defined security market is slated to touch a value of about US$ 3,800 Mn in the year 2022 and grow at a robust CAGR during the assessment period.  Request for Sample Report of "Software Defined Security" Market @ One of the major growth factor for the adoption of software defined security is the growing concern amongst the organizations using the virtual infrastructure and services of a
Public Cloud System Infrastructure Services Market Sales to Rake in Whopping US$ …
Public Cloud System Infrastructure Services Market 2022 The global public cloud system infrastructure services market is slated to touch a value of about US$ 110,350 Mn in the year 2025 and grow at a robust CAGR during the assessment period. Request for Sample Report of "Public Cloud System Infrastructure Services" Market @ The public cloud system infrastructure services market is driven by the advantages that the public cloud services possess. Due to the

All 5 Releases

More Releases for AML

ALSEGO’s New Automated AML Reporting Solution for Luxembourgish Banks
ALSEGO has launched a new automated AML Reporting solution aimed specifically at financial institutions in Luxembourg concerned with the Central Electronic Data Retrieval System (CEDRS) as stipulated in the CSSF circular 20/747. The solution is fully automated, however, if you wish to forgo a direct connection between the solution and your core-banking system, the solution functions with TSV/CSV files as well. The automatic functionalities of the solution are its key strengths.
Global AML Software Market Size, Status and Forecast
AML software is software used in the finance and legal industries to meet the legal requirements for financial institutions and other regulated entities to prevent or report money laundering activities. Europe to be the largest market for AML software during the forecast period. Though the Europe accounts for the largest market share, the APAC region is envisaged to witness the fastest growth during the predicted period. United States will still
Global AML Software Market Size, Status, Trends, Growth, Size, Segmentation, Sha …
The market for AML Software Market is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global AML Software Market Size, Status and Forecast 2018-2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions.
Global Anti-money Laundering Software Market 2015 | Major Key Players : ACI Worl …
Description : Technavio’s market research analyst predicts the global anti-money laundering (AML) software market to grow steadily at a CAGR of around 11% during the forecast period. AML software allows financial institutions and other enterprises to detect suspicious transactions and analyze customer data. Its ability to provide real-time alerts and tools to report suspicious events to maximize security and operational efficiency will foster its adoption during the forecast period. An important growth
Anti-money Laundering Software Global Market 2018: Key Players – ACI Worldwide …
Anti-money Laundering Software Industry Description Wiseguyreports.Com Adds “Anti-money Laundering Software -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database This report studies Anti-money Laundering Software in Global market, especially in North America, Europe, China, Japan, Korea and Taiwan, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering ACI Worldwide AML360 AML Partners AML RightSource BAE EastNets Experian
Quest CE Offers Anti-Money Laundering (AML) Training
Quest Continuing Education Solutions (Quest CE) is reminding producers that they offer the industry’s most affordable and comprehensive Anti-Money Laundering Training (AML) Solution. Quest CE’s AML course, titled “Anti-Money Laundering Regulations and Red Flag Requirements,” was recently authored and fulfills producer’s annual AML requirement. The course retails for $14.95 and is available for purchase at Quest CE’s proprietary Renaissance Learning Management System. If you would like to purchase the course